TFS Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

TFS Capital’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-80,012	Closed	-$1.67M	–	1024
2016 Q3	$1.67M	Buy	80,012 +68,366	+587%	+$787K	0.4%	60
2016 Q2	$126K	Buy	+11,646	New	+$99.6K	0.02%	832
2015 Q3	–	Sell	-14,889	Closed	-$214K	–	1175
2015 Q2	$214K	Buy	+14,889	New	+$202K	0.02%	742

TFS Capital's VTAE Position: Q4 2016 in Review

TFS Capital sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 80,012 shares — an estimated $1.67M sold.

TFS Capital first reported a position in VTAE in Q2 2015 and held it in 3 quarters. The position peaked at $1.67M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

TFS Capital reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
TFS Capital sold 80,012 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.67M.
TFS Capital first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2015 and held it in 3 quarters.
TFS Capital's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.67M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.